Following Protest, FDA Accepts Pharmacyclics’ Xcytrin NDA
This article was originally published in The Pink Sheet Daily
Executive Summary
CEO tells “The Pink Sheet” DAILY data slated for release at upcoming medical conferences could further support approval.